🚀 Apply for £10k+ grants with our Startup Launch Kit
shadow shadow shadow shadow shadow
    Country
    Opportunity Status
    Funding Instrument Type
    Category
    Clear

    NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)

    FOR-DA-26-006

    Lindsey Friend, Ph.D. National Institute on Drug Abuse (NIDA) NIDA Office of Research Training and Career Development

    Opening date 27 May 2025, 12:00AM

    Closing date N/A

    Funding Opportunity Number: FOR-DA-26-006

    Opportunity Category: Discretionary

    CFDA Number(s): 93.279 -- Drug Use and Addiction Research Programs

    Cost Sharing or Matching Requirement: No

    Posted Date: May 27, 2025 12:00:00 AM EDT

    Closing Date: N/A

    Eligible Applicants: Public and State controlled institutions of higher education,Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education,Native American tribal organizations (other than Federally recognized tribal governments),Native American tribal governments (Federally recognized),Private institutions of higher education

    Description:

    The National Institute on Drug Development (NIDA) intends to publish a Notice of Funding Opportunity (NOFO) to support applications for institutional research career development (K12) programs that propose to support intensive supervised research training and career development experiences for clinician scientists (Scholars) leading to research independence in the area of substance use and substance use disorder research. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the K12 activity code. Investigators are encouraged to consider applying to this NOFO for projects in NIDA's science areas including (but not limited to): neuroimaging, genetics, medication and treatment development, development of new and improved strategies to prevent substance use, neuroimmune signaling, neuropathology in brain systems, cognitive processes, population neuroscience, HIV and drugs of abuse, medication development, epidemiology, identifying the biological consequences of substance use and addiction across the lifespan, and implementation science. In addition, collaborative investigations combining expertise in substance use disorders, pain, or HIV will be encouraged, and these investigators should also begin considering applying for this application. 

    We use cookies and similar technologies that are necessary to operate the website.Please read our cookie policy.

    We use cookies and similar technologies that are necessary to operate the website. Additional cookies are only used with your consent. We use the additional cookies to perform analyses of website usage and to check marketing measures for their efficiency. These analyses are carried out to provide you with a better user experience on the website. You are free to give, deny, or withdraw your consent at any time by using the "cookie settings" link at the bottom of each page. You can consent to our use of cookies by clicking "Agree". For more information about what information is collected and how it is shared with our partners, please read our cookie policy.

    • Required to run the website
    • Monitoring website usage and optimizing the user experience
    • Evaluation of marketing actions
    • Storage of your preferences from previous visits
    • Collecting user feedback to improve our website
    • Recording of your interests in order to provide customised content and offers
    Cookie Settings Accept